Intellectual Property India Publishes Patent Application for 'Plasminogen (PLG) IRNA Compositions And Methods Of Use Thereof' Filed by Alnylam Pharmaceuticals, Inc.

MUMBAI, India, May 30 -- Intellectual Property India has published a patent application (202517044133 A) filed by Alnylam Pharmaceuticals, Inc., Cambridge, U.S.A., on May 7, for 'plasminogen (plg) irna compositions and methods of use thereof.'

Inventor(s) include Slingsby, Martina; Holmes, Benjamin; Fishilevich, Elane; Zuber, Jeffrey; Maratos-Flier, Eleftheria; and Gansner, John.

The application for the patent was published on May 30, under issue no. 22/2025.

According to the abstract released by the Intellectual Property India: "The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the plasminogen (PLG) gene, as well as methods of inhibiting expression of PLG, and methods of treating subjects that woul...